• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    US Test Strip Market

    ID: MRFR/MED/18506-HCR
    100 Pages
    Rahul Gotadki
    September 2025

    US Test Strip Market Research Report By Product Type (Urine Test Strip, Diabetic Strips, Fluorescein), By Application (Disease Diagnosis, Pregnancy Test), By Function (Visual Test Strips, Automated Test Strips) and By End User (Institutes & Research Laboratories, Hospital & Clinics, Diagnostic Laboratories) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    US Test Strip Market Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Table of Contents

    US Test Strip Market Summary

    The US Test Strip market is projected to grow from 1.6 USD Billion in 2024 to 3.5 USD Billion by 2035.

    Key Market Trends & Highlights

    US Test Strip Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 7.38 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 3.5 USD Billion, indicating robust growth potential.
    • In 2024, the market is valued at 1.6 USD Billion, reflecting a strong foundation for future expansion.
    • Growing adoption of advanced diagnostic technologies due to increasing prevalence of chronic diseases is a major market driver.

    Market Size & Forecast

    2024 Market Size 1.6 (USD Billion)
    2035 Market Size 3.5 (USD Billion)
    CAGR (2025-2035) 7.38%

    Major Players

    Siemens Healthineers, Glucorelish, Acon Laboratories, HoffmannLa Roche, Roche, Nova Biomedical, HTC Health, Bayer, Caresens, Abbott Laboratories, Ascensia Diabetes Care, Optimum Health, Medtronic, Dexcom, LifeScan

    US Test Strip Market Trends

    The US Test Strip Market is experiencing significant trends driven by the increasing prevalence of diabetes and the need for effective monitoring solutions. The rise in lifestyle-related conditions and aging population contribute to a growing demand for test strips, particularly as more individuals are diagnosed with diabetes.

    Furthermore, technological advancements, such as the development of smart-test strips that integrate with mobile applications, are changing the landscape of blood glucose monitoring, offering more convenient and accurate ways to track health. Opportunities in the US market include the expansion of home healthcare and point-of-care testing.

    As patients increasingly prefer convenience and remote health monitoring, manufacturers are encouraged to innovate and enhance their product offerings. The potential for collaboration between test strip manufacturers and technology companies also remains substantial, as this could lead to improved data management and user experience.

    Recent times have witnessed trends emerging from regulatory changes as well. The Food and Drug Administration has introduced measures to streamline the approval process for digital health devices, including blood glucose monitors and associated test strips. This creates an avenue for new entrants into the market, fostering competition and innovation. Additionally, there is a growing emphasis on affordability and accessibility of diabetes management tools in the United States, reflecting the healthcare system's push towards reducing costs for patients.

    As awareness regarding diabetes management continues to rise, the need for better access to testing supplies and supportive technology will remain prevalent in the evolving US Test Strip Market.

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    US Test Strip Market Drivers

    Market Segment Insights

    Test Strip Market Product Type Insights

    The US Test Strip Market is experiencing significant evolution, particularly in the product type segment, which encompasses a variety of test strips including Urine Test Strips, Diabetic Strips, and Fluorescein strips. Each of these types plays a vital role in healthcare, contributing to the overall market growth and advancement in diagnostics.

    Meanwhile, Diabetic Strips dominate the market, driven by the increasing incidence of diabetes across the United States. With over 34 million Americans diagnosed with diabetes, the demand for reliable blood glucose monitoring tools such as diabetic strips has surged in recent years. This segment’s importance cannot be overstated, as it contributes to effective diabetes management and is crucial for preventing complications associated with the disease.

    Fluorescein strips, although less common than the previously mentioned types, hold significant value particularly in the ophthalmic space. Their application in detecting corneal abrasions and other eye conditions has made them indispensable within healthcare settings. The focus on improving patient outcomes continues to drive innovation and enhancements within this segment. Notably, the US Test Strip Market revenue is underpinned by technological advancements that streamline the manufacturing process and lead to more accurate results.

    Overall, market growth in this segment can be attributed to the rising awareness of preventative healthcare, the proliferation of chronic diseases, and active initiatives aimed at facilitating self-monitoring among patients. The healthcare industry in the US is increasingly prioritizing point-of-care testing solutions, highlighting the critical importance of these product types in meeting the diverse needs of patients and healthcare providers alike. As a result, the US Test Strip Market statistics reflect a dynamic and competitive landscape where the need for efficiency and accuracy drives ongoing innovations and product diversification.

    Test Strip Market Application Insights

    The Application segment of the US Test Strip Market plays a crucial role in the healthcare landscape, particularly in areas such as Disease Diagnosis and Pregnancy Testing. The Disease Diagnosis category has gained significant attention due to the increasing prevalence of chronic diseases, prompting swift advancements in point-of-care testing.

    These Tests are generally favored for their ease of use and rapid results, making them a preferred choice among consumers. The US Test Strip Market segmentation reflects a clear trend towards convenience and immediate results, aligning with patients' increasing expectations for timely healthcare interventions. Factors such as technological innovations alongside the expansion of healthcare services are likely to drive growth in these applications, while challenges may arise from regulatory hurdles and the need for continuous improvement in test accuracy and reliability, particularly in the context of Disease Diagnosis.

    Overall, these segments are critical to understanding the dynamics of the market and the ongoing shifts in consumer behavior as it adapts to evolving healthcare demands.

    Test Strip Market Function Insights

    The Function segment of the US Test Strip Market plays a critical role in the healthcare landscape, particularly for individuals managing diabetes and other chronic conditions. The market is increasingly divided into two main categories Visual Test Strips and Automated Test Strips.

    The growing awareness of diabetes and the increasing prevalence of metabolic disorders in the US significantly contribute to the market growth. Moreover, the ongoing advancements in technology are expected to enhance the functionality of automated testing, further driving demand. Challenges such as market saturation and regulatory hurdles must be navigated, but ample opportunities exist for innovation and expansion within the Function segment as the US healthcare system increasingly focuses on personalized medicine and patient-centric care approaches.

    Test Strip Market End User Insights

    The End User segment of the US Test Strip Market is critical in shaping the market's dynamics, with key players including Institutes and Research Laboratories, Hospitals and Clinics, and Diagnostic Laboratories. Hospitals and Clinics represent a significant portion of the market, as they require test strips for immediate patient care and routine health monitoring.

    Overall, the interdependence of these sectors showcases their significance in health care delivery and medical advancements in the US, where the demand for reliable and efficient testing continues to grow in response to evolving health challenges. The insights pertaining to the End User segment reflect essential trends in the US Test Strip Market, including the increasing emphasis on rapid diagnostics and home monitoring solutions.

    Get more detailed insights about US Test Strip Market

    Regional Insights

    Key Players and Competitive Insights

    The US Test Strip Market is characterized by a dynamic environment with several key players striving to establish strong competitive advantages through innovation, quality, and regulatory compliance. The industry focuses on the production and distribution of test strips primarily for diabetes management, urinalysis, and other diagnostic purposes. The market has been driven by the rising prevalence of chronic diseases, increased health awareness among consumers, and advancements in technology that have made test strips more user-friendly and efficient.

    Competitive insights reveal a landscape where companies not only compete on product efficacy but also on accessibility, pricing strategies, and the ability to offer comprehensive health monitoring solutions. Collaborations and partnerships among healthcare providers, technology firms, and research institutions are also becoming increasingly common as businesses seek to enhance their market presence and respond to consumer needs.

    Siemens Healthineers stands as a prominent player in the US Test Strip Market, leveraging its strong brand reputation and expertise in medical technology to provide innovative diagnostic solutions. The company’s strengths lie in its commitment to research and development, ensuring that it remains at the forefront of technological advancements in testing. Siemens Healthineers is recognized for its high-quality test strips that deliver accurate and reliable results, thereby enhancing patient outcomes. The company's extensive experience in the healthcare sector enhances its capability to navigate regulatory challenges effectively and establish strong distribution networks across the United States.

    Additionally, Siemens Healthineers invests heavily in training healthcare professionals to maximize the efficacy of its diagnostic tests, which further strengthens its market position.

    Glucorelish, another key competitor in the US Test Strip Market, specializes in developing and manufacturing test strips specifically designed for glucose monitoring in diabetic patients. The company’s product portfolio includes a range of affordable and easy-to-use test strips that align with current consumer expectations for convenience and efficiency. Glucorelish has established a significant market presence through strategic partnerships and an emphasis on customer service, ensuring that products are accessible to a larger demographic. The company’s strengths include a strong focus on innovation, which has led to the development of advanced testing solutions that minimize errors and enhance user experience.

    Furthermore, Glucorelish has pursued various mergers and acquisitions to expand its capabilities and product offerings in the US market, solidifying its position as a trusted provider of essential diagnostic tools in the diabetes care sector.

    Key Companies in the US Test Strip Market market include

    Industry Developments

    In recent months, notable developments in the US Test Strip Market have emerged, reflecting the growth and ongoing innovation within the industry. Siemens Healthineers has expanded its product portfolio, launching new glucose test strips aimed at enhancing user experience and accuracy. Meanwhile, Abbott Laboratories is witnessing significant growth in its FreeStyle line of diabetic test strips, further solidifying its position in the market.

    The demand for innovative solutions in diabetes management continues to drive partnerships, with Acon Laboratories announcing collaborations to improve distribution efficiency. In terms of mergers and acquisitions, F. Hoffmann-La Roche has been active, acquiring a smaller biotech company in September 2023 to bolster its diabetes care capabilities. This acquisition aligns with the growing trend towards integrated health solutions within the diabetes management sector.

    Another significant event occurred in June 2022 when Medtronic expanded its partnership with Dexcom, focusing on advancing continuous glucose monitoring technology. The US Test Strip Market's valuation is positively influenced by increasing investments in Research and Development, with companies such as Nova Biomedical and Ascensia Diabetes Care leading the innovation charge, further stating the market's potential for growth in the coming years.

    Market Segmentation

    Test Strip Market End User Outlook

    • Institutes & Research Laboratories
    • Hospital & Clinics
    • Diagnostic Laboratories

    Test Strip Market Function Outlook

    • Visual Test Strips
    • Automated Test Strips

    Test Strip Market Application Outlook

    • Disease Diagnosis
    • Pregnancy Test

    Test Strip Market Product Type Outlook

    • Urine Test Strip
    • Diabetic Strips
    • Fluorescein

    Report Scope

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Leave a Comment

    FAQs

    What is the expected market size of the US Test Strip Market in 2024?

    The US Test Strip Market is expected to be valued at 1.6 billion USD in 2024.

    What is the projected market value of the US Test Strip Market in 2035?

    The market is projected to reach a value of 3.5 billion USD by 2035.

    What is the expected CAGR for the US Test Strip Market from 2025 to 2035?

    The expected CAGR for the US Test Strip Market from 2025 to 2035 is 7.375%.

    How much is the Urine Test Strip segment expected to be worth in 2035?

    The Urine Test Strip segment is expected to be valued at 1.32 billion USD in 2035.

    What is the projected market value of Diabetic Strips in 2024?

    Diabetic Strips are projected to be valued at 0.72 billion USD in 2024.

    What are the key competitors in the US Test Strip Market?

    Key competitors include Siemens Healthineers, Acon Laboratories, Roche, Abbott Laboratories, and Dexcom.

    What is the anticipated market size for Fluorescein Test Strips in 2035?

    The Fluorescein Test Strips segment is anticipated to be worth 0.49 billion USD by 2035.

    What opportunities exist for growth in the US Test Strip Market?

    Opportunities for growth include advancements in technology and increasing global health awareness.

    What challenges might impact the US Test Strip Market in the coming years?

    Challenges may include regulatory hurdles and market competition affecting profit margins.

    How does the regional market size for the US Test Strip Market compare globally?

    The US Test Strip Market is among the largest in the world, driven by high healthcare expenditure and innovation.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. US Test Strip Market, BY Product Type (USD Billion)
    45. Urine Test Strip
    46. Diabetic Strips
    47. Fluorescein
    48. US Test Strip Market, BY Application (USD Billion)
    49. Disease Diagnosis
    50. Pregnancy Test
    51. US Test Strip Market, BY Function (USD Billion)
    52. Visual Test Strips
    53. Automated Test Strips
    54. US Test Strip Market, BY End User (USD Billion)
    55. Institutes & Research Laboratories
    56. Hospital & Clinics
    57. Diagnostic Laboratories
    58. Competitive Landscape
    59. Overview
    60. Competitive Analysis
    61. Market share Analysis
    62. Major Growth Strategy in the Test Strip Market
    63. Competitive Benchmarking
    64. Leading Players in Terms of Number of Developments in the Test Strip Market
    65. Key developments and growth strategies
    66. New Product Launch/Service Deployment
    67. Merger & Acquisitions
    68. Joint Ventures
    69. Major Players Financial Matrix
    70. Sales and Operating Income
    71. Major Players R&D Expenditure. 2023
    72. Company Profiles
    73. Siemens Healthineers
    74. Financial Overview
    75. Products Offered
    76. Key Developments
    77. SWOT Analysis
    78. Key Strategies
    79. Glucorelish
    80. Financial Overview
    81. Products Offered
    82. Key Developments
    83. SWOT Analysis
    84. Key Strategies
    85. Acon Laboratories
    86. Financial Overview
    87. Products Offered
    88. Key Developments
    89. SWOT Analysis
    90. Key Strategies
    91. HoffmannLa Roche
    92. Financial Overview
    93. Products Offered
    94. Key Developments
    95. SWOT Analysis
    96. Key Strategies
    97. Roche
    98. Financial Overview
    99. Products Offered
    100. Key Developments
    101. SWOT Analysis
    102. Key Strategies
    103. Nova Biomedical
    104. Financial Overview
    105. Products Offered
    106. Key Developments
    107. SWOT Analysis
    108. Key Strategies
    109. HTC Health
    110. Financial Overview
    111. Products Offered
    112. Key Developments
    113. SWOT Analysis
    114. Key Strategies
    115. Bayer
    116. Financial Overview
    117. Products Offered
    118. Key Developments
    119. SWOT Analysis
    120. Key Strategies
    121. Caresens
    122. Financial Overview
    123. Products Offered
    124. Key Developments
    125. SWOT Analysis
    126. Key Strategies
    127. Abbott Laboratories
    128. Financial Overview
    129. Products Offered
    130. Key Developments
    131. SWOT Analysis
    132. Key Strategies
    133. Ascensia Diabetes Care
    134. Financial Overview
    135. Products Offered
    136. Key Developments
    137. SWOT Analysis
    138. Key Strategies
    139. Optimum Health
    140. Financial Overview
    141. Products Offered
    142. Key Developments
    143. SWOT Analysis
    144. Key Strategies
    145. Medtronic
    146. Financial Overview
    147. Products Offered
    148. Key Developments
    149. SWOT Analysis
    150. Key Strategies
    151. Dexcom
    152. Financial Overview
    153. Products Offered
    154. Key Developments
    155. SWOT Analysis
    156. Key Strategies
    157. LifeScan
    158. Financial Overview
    159. Products Offered
    160. Key Developments
    161. SWOT Analysis
    162. Key Strategies
    163. References
    164. Related Reports
    165. US Test Strip Market SIZE ESTIMATES & FORECAST, BY PRODUCT TYPE, 2019-2035 (USD Billions)
    166. US Test Strip Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)
    167. US Test Strip Market SIZE ESTIMATES & FORECAST, BY FUNCTION, 2019-2035 (USD Billions)
    168. US Test Strip Market SIZE ESTIMATES & FORECAST, BY END USER, 2019-2035 (USD Billions)
    169. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    170. ACQUISITION/PARTNERSHIP
    171. MARKET SYNOPSIS
    172. US TEST STRIP MARKET ANALYSIS BY PRODUCT TYPE
    173. US TEST STRIP MARKET ANALYSIS BY APPLICATION
    174. US TEST STRIP MARKET ANALYSIS BY FUNCTION
    175. US TEST STRIP MARKET ANALYSIS BY END USER
    176. KEY BUYING CRITERIA OF TEST STRIP MARKET
    177. RESEARCH PROCESS OF MRFR
    178. DRO ANALYSIS OF TEST STRIP MARKET
    179. DRIVERS IMPACT ANALYSIS: TEST STRIP MARKET
    180. RESTRAINTS IMPACT ANALYSIS: TEST STRIP MARKET
    181. SUPPLY / VALUE CHAIN: TEST STRIP MARKET
    182. TEST STRIP MARKET, BY PRODUCT TYPE, 2025 (% SHARE)
    183. TEST STRIP MARKET, BY PRODUCT TYPE, 2019 TO 2035 (USD Billions)
    184. TEST STRIP MARKET, BY APPLICATION, 2025 (% SHARE)
    185. TEST STRIP MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)
    186. TEST STRIP MARKET, BY FUNCTION, 2025 (% SHARE)
    187. TEST STRIP MARKET, BY FUNCTION, 2019 TO 2035 (USD Billions)
    188. TEST STRIP MARKET, BY END USER, 2025 (% SHARE)
    189. TEST STRIP MARKET, BY END USER, 2019 TO 2035 (USD Billions)
    190. BENCHMARKING OF MAJOR COMPETITORS

    US Test Strip Market Segmentation

     

    • Test Strip Market By Product Type (USD Billion, 2019-2035)
      • Urine Test Strip
      • Diabetic Strips
      • Fluorescein
    • Test Strip Market By Application (USD Billion, 2019-2035)
      • Disease Diagnosis
      • Pregnancy Test
    • Test Strip Market By Function (USD Billion, 2019-2035)
      • Visual Test Strips
      • Automated Test Strips
    • Test Strip Market By End User (USD Billion, 2019-2035)
      • Institutes & Research Laboratories
      • Hospital & Clinics
      • Diagnostic Laboratories
    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials